The Pan-Cancer Atlas: Charting a Course to a Cure
Originally Aired: May 22, 2018
From the analysis of over 10,000 tumors from 33 of the most prevalent forms of cancer, the Pan-Cancer Atlas provides a uniquely comprehensive, in-depth, and cohesive understanding of how, where, and why tumors arise in humans. The Atlas reveals a new clustering of tumor types that will inform future clinical trials, grouping tumors based on molecular similarity and with a greater understanding of how their tissue of origin influences a cancer’s features. In its comprehensive analysis of tumor pathways, the Pan-Cancer Atlas reveals new patterns of potential vulnerabilities that will aid in the development of combination therapies and personalized medicine, providing a global map for human cancer research.
In this Cell Press webinar, TCGA members Katherine Hoadley (University of North Carolina, Chapel Hill), Nikolaus Schultz (Memorial Sloan Kettering Cancer Center), and Li Ding (Washington University in St. Louis) will share the latest insights from this decade-long collaboration. Jean Claude Zenklusen, director of The Cancer Genome Atlas (TCGA) consortium, will moderate and provide a brief overview of the consortium.
Assistant Professor of Cancer Genetics
University of North Carolina, Chapel Hill